Vantage Private Equity Growth 2 (VPEG2) is a Private Equity Fund of Funds established to provide investors with access to the returns generated by the top performing Buyout and Later Expansion Private Equity Funds in Australia.

Private Equity as an asset class has attracted a growing amount of interest from investors over recent years as it continues to outperform traditional asset classes. VPEG2 offers investors the opportunity to share in the strong returns of this asset class, while substantially removing the hurdles that have traditionally limited investor access to it.

Through its unique structure, focussed investment strategy and guidelines, systematic and rigorous fund manager selection criteria and its arrangements with highly experienced Private Equity investment management and advisory groups, the Manager is confident of VPEG2 delivering superior absolute returns to Investors.

Vantage Private Equity Growth 2 (VPEG2)

COVID-19 Portfolio Update

The following points provide a summary overview of the analysed impact of COVID-19 to VPEG2’s underlying portfolio;

  • VPEG2 has a well-balanced portfolio of 45 underlying company investments, diversified across a range of industry sectors and geographic regions within Australia and New Zealand, all of which are impacted in different ways by COVID-19.
  • 36 portfolio companies representing 72.6% of VPEG2’s Net Asset Value (NAV) operate Essential Service businesses or provide a majority of their products and services to Essential Service businesses as defined under current Australian and New Zealand Government COVID-19 business definitions
  • 34 portfolio companies representing 72.1% of VPEG2’s NAV have reported either a net benefit or a low impact to their financial performance as a result of each Government’s imposed COVID-19 restrictions on the economy
  • VPEG2’s portfolio of investments generally have a low to moderate level of gearing, with a majority of companies still generating good cashflows and either have sufficient cash reserves or the ability to draw down on existing finance facilities to satisfy their financial obligations, should a prolonged economic downturn persist.

Download VPEG2's COVID-19 Portfolio here

Investment Highlights

VPEG2 Quarterly Report March 2020 Special Points of Interest;

  • Mercury Capital Fund 2 invests in National Express Products, a New Zealand headquartered office and facility supply business
  • Waterman Capital Fund 3 investee TRG Imaging, completes the bolt-on acquisition of Canopy Cancer Care, New Zealand’s leading private clinic for adult cancer patients
  • A majority of VPEG2’s underlying portfolio have reported a net benefit or a low impact to their revenues as a result of the current COVID-19 operating environment

Read More

Download or view a copy of the VPEG2 Quarterly Report March 2020

Key Facts

Twin Australian Unit Trusts

Underlying Investments
Unlisted, closed end Australian Buyout & Later Expansion Private Equity Funds

Target return
20% p.a

Minimum Commitment / Trust Investment
Trust A; $5,000,000
Trust B; $50,000

Distributions to Unit holders
At least every 12 months, more frequent as underlying investments are divested over time

Manager & Trustee
Vantage Asset Management Pty Limited

Final Close Completed
28 May 2015